RECITALSAssignment, Transfer and Assumption Agreement • April 4th, 2008 • Xanodyne Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2008 Company Industry Jurisdiction
ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENT (VANCOCIN)Assignment, Transfer and Assumption Agreement • November 24th, 2004 • Viropharma Inc • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 24th, 2004 Company Industry JurisdictionThis ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENT (this “Agreement”) is entered into as of October 18, 2004 (the “Effective Date”), by and between ViroPharma Incorporated (“ViroPharma”), a corporation organized and existing under the laws of the State of Delaware with offices located at 397 Eagleview Boulevard, Exton, PA 19341 and Eli Lilly and Company (“Lilly”), a corporation organized and existing under the laws of the State of Indiana with offices located at Lilly Corporate Center, Indianapolis, Indiana 46285. ViroPharma and Lilly are sometimes referred to herein individually as a “Party” and collectively as “Parties”.
ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENTAssignment, Transfer and Assumption Agreement • October 26th, 2020 • Mavenir Private Holdings II Ltd. • Services-prepackaged software
Contract Type FiledOctober 26th, 2020 Company IndustryThis ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENT (this “Agreement”) is made as of October [●], 2020, by and between Sierra Private Investments, L.P. (“Assignor”) and Mavenir Systems, Inc. (“Assignee”).
Exhibit No. DescriptionAssignment, Transfer and Assumption Agreement • April 10th, 2008
Contract Type FiledApril 10th, 2008
AMENDMENT NO. 1 TO ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENTAssignment, Transfer and Assumption Agreement • November 24th, 2004 • Viropharma Inc • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 24th, 2004 Company Industry JurisdictionThis AMENDMENT NO. 1 dated as of November 9, 2004 (this “Amendment”) amends that certain Assignment, Transfer and Assumption Agreement dated as of October 18, 2004 (the “Assignment Agreement”) by and between ViroPharma Incorporated (“ViroPharma”), a corporation organized and existing under the laws of the State of Delaware with offices located at 397 Eagleview Boulevard, Exton, Pennsylvania 19341 and Eli Lilly and Company (“Lilly”), a corporation organized and existing under the laws of the State of Indiana with offices located at Lilly Corporate Center, Indianapolis, Indiana 46285.
ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENTAssignment, Transfer and Assumption Agreement • January 2nd, 2003 • Galen Holdings PLC • Pharmaceutical preparations • New York
Contract Type FiledJanuary 2nd, 2003 Company Industry JurisdictionThis ASSIGNMENT, TRANSFER AND ASSUMPTION AGREEMENT (the "Agreement") is entered into as of December 7, 2002 (the "Effective Date"), by and between Galen (Chemicals) Limited ("Galen"), a company organized and existing under the laws of the Republic of Ireland with offices located at 4 Adelaide Street, Dun Laoghaire, Co. Dublin, Ireland, and Eli Lilly and Company ("Lilly"), a corporation organized and existing under the laws of the State of Indiana with offices located at Lilly Corporate Center, Indianapolis, Indiana 46285. Galen and Lilly are sometimes referred to herein individually as a "Party" and collectively as "Parties".